v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 213.0 $ 228.3
Adjustments to reconcile net earnings to net cash provided by (used for) operating activities:    
Depreciation and amortization 166.8 154.5
Stock compensation 32.8 31.6
Operating lease right-of-use asset expense 48.6 44.1
Goodwill and other asset impairments 0.0 2.5
Deferred income taxes (6.1) (19.5)
Other, net 8.1 (3.0)
Change in assets and liabilities (net of effects of acquisitions and divestitures):    
Increase in accounts receivable (170.8) (187.1)
Decrease in unbilled services 3.9 63.9
Decrease (increase) in supplies inventory 8.4 (0.6)
Decrease (increase) in prepaid expenses and other (45.0) 24.9
Decrease in accounts payable (147.6) (121.1)
Decrease in unearned revenue (8.9) (41.6)
Decrease in accrued expenses and other (174.7) (156.9)
Net Cash Provided by (Used in) Operating Activities, Total 18.5 (29.8)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (126.0) (133.8)
Proceeds from sale of assets 0.5 0.1
Proceeds from sale of business 0.0 13.5
Investments in equity affiliates (157.0) (13.7)
Acquisition of businesses, net of cash acquired (53.5) (259.2)
Net cash used for investing activities (336.0) (393.1)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments on senior notes (1,000.0) 0.0
Proceeds from revolving credit facilities 64.8 253.2
Payments on revolving credit facilities (64.8) (210.8)
Proceeds from accounts receivable securitization 225.0 0.0
Net share settlement tax payments from issuance of stock to employees 25.5 14.7
Net proceeds from issuance of stock to employees 25.7 26.7
Dividends paid 61.6 62.1
Other (3.3) (4.0)
Net cash used for financing activities (839.7) (11.7)
Effect of exchange rate changes on Cash and cash equivalents 7.9 (2.9)
Net decrease in cash and cash equivalents (1,149.3) (437.5)
Cash and cash equivalents at beginning of period 1,518.7 536.8
Cash and cash equivalents at end of period $ 369.4 $ 99.3